Featured

Climate tech’s shaky footing in 2025 â This Week in Cleantech

This Week in Cleantech is a weekly podcast covering the most impactful stories in clean energy and climate in 15 minutes.

4 min read

Business News Podcasts

Renewables

Factor This finance and development roundup: Atlas Renewable Energy, Exowatt, Lightshift Energy, Omnidian, OnePlanet, Standard Solar, Trina Storage

This week saw finance and project development updates from Atlas Renewable Energy, Exowatt, Lightshift Energy, Omnidian, OnePlanet, Standard Solar, and Trina Storage.

12 min read

Business Finance News

a 'no war' sign next to a solar manufacturing line

Renewables

Electricity demand is skyrocketing; US manufacturers don’t have time for a trade war and tax credit uncertainty

Back-and-forth tariff policies threaten the business plans of American manufacturers who depend on imports to create domestic jobs.

7 min read

Business News Policy & Regulation

a person holding a Heimdall neuron ball standing in front of transmission lines

Power Grid

Why more electric utilities are trying on the ‘Apple Watch’ of the power grid

Grid-enhancing technologies like Heimdall Power’s Neuron can unlock more than 40% more capacity on high-voltage power lines.

10 min read

News Power Grid Smart Grids

DTECH Data Centers & AI 2025

May 27-29, 2025 | San Jose, CA

Tackling booming data center growth to shape the future of the grid.

Learn More

Renewables

New solar grassroots advocacy platform launched to protect clean energy tax credits

With both chambers of Congress preparing to return to Washington to negotiate a budget reconciliation package, SEIA is hoping to mobilize people across the country…

3 min read

Cool solar tech: Who’s ready for AI-powered construction robots and quantum dots?

Cosmic Robotics, an AI-powered construction company, and UbiQD, a quantum dot manufacturer, could both help the U.S. solar industry.

7 min read

Finance News Solar

trucks lined up below solar panels on a building rooftop

US solar manufacturers, rejoice! Southeast Asian solar imports tariffed into oblivion

Commerce has made final affirmative determinations in a major solar cell antidumping duty and countervailing duty (AD/CVD) case.

5 min read

Business News Policy & Regulation

AES Indiana honors Earth Day with two new clean energy projects

The utility announced the full operations of the Pike County Battery Energy Storage System (BESS) and approval by the Indiana Utility Regulatory Commission (IURC) to…

2 min read

Energy Storage News Solar

China dominates solar. Trump tariffs target China. For US solar industry, that means higher costs

President Donald Trump’sÂ escalating trade war with ChinaÂ threatens to crimp a massive source of solar panels and parts, with experts saying the cost of projects will…

5 min read

Business News Policy & Regulation

Hydropower

State-owned Ukrainian hydro company receives first tranche of EBRD loans to rebuild destroyed generation

The purpose of the project is to restore some of Ukraine’s energy infrastructure that was damaged or destroyed as part of the Russian military invasion,…

2 min read

Business Hydropower News

This new tech catalog could help streamline hydropower development for utilities

The Hydropower Technology Catalog is designed to help utilities identify the best components for hydropower construction or upgrades.

3 min read

Hydropower News

Utah governor considers emergency declaration as drought worsens in southern Utah and Lake Powell levels drop

According to the Utah Rivers Council, Lake Powell is about 70 feet above the minimum level for the Glen Canyon Dam to generate hydroelectric power.

5 min read

Hydropower News

Hawaii PUC approves amended contract with Wailuku River Hydroelectric on Hawaii Island

The Hilo plant has supplied the island’s grid with up to 12.1 megawatts (MW) of run-of-river energy since 1993.

2 min read

Hydropower News Small Hydropower

Vast majority of Canadians support new hydro development, survey finds

Affordability, economic benefits, and reliability are top drivers of public support across age groups and political affiliations.

3 min read

Hydropower News

Power Grid

New Jersey Governor wants feds to investigate higher PJM electricity prices

The fight between New Jersey Democrats and the stateâs electric grid operator escalated this week, with Gov. Phil Murphy asking federal officials to investigate whether…

4 min read

Business News Policy & Regulation

At Trump’s request, FERC Commissioner Phillips steps down

With Phillips’ departure, Democrats lose their majority in FERC, resulting in a 2-2 split on party lines.

2 min read

Business News Policy & Regulation

For $2.4 billion, this bill aims to lower CT electric bills. Why are both parties split?

Despite some bipartisan support, a bill by Democratic state Sen. John Fonfara has also stoked inter-party divisions.

13 min read

Business News Policy & Regulation

As wildfires intensify, utilities want liability protections. But then who pays?

Power companies say they face bankruptcy or rate hikes due to growing risk.

7 min read

Business News Outage Management

Do Xcelâs internal transmission studies duplicate MISOâs DER-affected systems studies?

Duplicate studies are dragging the timeline to interconnect community solar gardens in Minnesota, which could have a ripple effect on all DER interconnections at MISO,…

5 min read

News Power Grid Transmission

Webinars

Mar 27

Power Grid

Modern Grid Operationsâ Dependence on Advanced Planning

The electric grid is becoming increasingly complex with higher penetrations of distributed energy resources (DERs), hyperscaling demand driven by large loads from the use of…

Mar 26

Power Grid

How Alectra Energy Solutions and Caterpillar helped a Large Manufacturer Solve Their Rising Energy Costs Through Assets, Technology and Financial Structuring.

March 26th 2ET- Join Caterpillarâs Stephanie Baughman and Dean Musser as they shine the spotlight on a project that did just that, bringing together the expertise of an equipment and technology provider and a local utility affiliate to deliver near-term and future energy cost savings to a large industrial customer.

Mar 26

Power Grid

Realizing autonomous energy systems with generative AI Tackling an increasingly complex energy grid with minimal human intervention

This panel will explore the intersection of generative AI (GenAI)and autonomous energy systems (AES) in tackling increasingly complex energy landscapes. As renewable energy sources, electric…

Emerging Stocks in Telehealth: (MGRX, HIMS, GDRX, TDOC)

By: AB Newswire

June 13, 2023 at 13:56 PM EDT

The telehealth market is booming, presenting potentially lucrative opportunities for investors. With a projected CAGR of approximately 18.81% from 2022 to 2030, the global telehealth market is set for significant expansion.

Valued at around USD 41.01 billion in 2021, this market is expected to reach USD 224.87 billion by 2030. As technology advances and consumer preferences evolve, telehealth is revolutionizing healthcare delivery. In this article, we explore four emerging companies at the forefront of this growing industry, offering innovative telemedicine platforms and digital health solutions. Join us as we uncover the investment prospects in this rapidly expanding telehealth market.

MANGOCEUTICALS INC. (NASDAQ: MGRX)

MGRX is an emerging telehealth company focused on men's health and wellness solutions. With the men's health market projected to grow at a CAGR of 15.00% by 2029, Mangoceuticals is well-positioned to capitalize on this booming industry.

Earlier in the year, MGRX successfully concluded its IPO, generating $5,000,000 in gross proceeds. These funds will support the planned launch of Mango, the company's flagship product. Mangoceuticals aims to utilize the funds for marketing initiatives, talent acquisition, software development, and general corporate purposes.

MGRX differentiates itself by formulating expertly crafted compounds, ensuring an exceptional customer experience. Through their secure telemedicine platform, MangoRx, the company offers convenient access to Mango, a groundbreaking solution designed to address men's unique concerns.

Mango stands out with its rapid-dissolving mango-flavored tablets, which provide quicker results by efficiently entering the bloodstream. Crafted with FDA-approved ingredients and a proprietary blend, Mango offers a tasty, efficient, and powerful solution for men seeking relief from specific health challenges.

In line with its growth-oriented marketing strategy, last week, MGRX announced its sponsorship of the hugely popular Barstool Sports Only Stans podcast. This sponsorship provides access to a massive audience of more than 320,000 listeners per episode, which resonates well with the company's target market. Mangoceuticals is excited about the opportunity to showcase its product benefits to the podcast's listeners, potentially generating new interest among customers and investors.

Expanding its market reach, MGRX has made Mango available in 44 states, including Nevada and the District of Columbia. This milestone highlights the company's commitment to growth and accessibility for potential customers.

Investors seeking opportunities in the telehealth sector should consider MGRX and its unique position in the growing men's health market. With its innovative products, successful IPO, and focus on men's health and wellness, Mangoceuticals is poised to make a significant impact in the market.

By seamlessly integrating its telemedicine platform, differentiated product offering, and strategic marketing initiatives, Mangoceuticals presents a compelling investment opportunity for those interested in the telehealth sector.

HIMS & HERS HEALTH INC. (NYSE: HIMS)

HIMS is a leading telemedicine company that offers virtual consultations and personalized prescriptions for various health and wellness issues. With a strong focus on convenience and accessibility, Hims & Hers provides a seamless online platform where patients can sign up and connect with licensed healthcare providers who diagnose and prescribe medications as needed.

The fact that the company currently serves less than 1% of young adults in the United States underscores its impressive growth potential, leaving plenty of room for expansion within its target market of 140 million Gen Zers and millennials. Furthermore, Hims & Hers has yet to tap into markets such as obesity and diabetes, presenting additional avenues for future growth.

Notably, Hims & Hers demonstrated an 88% year-over-year increase in subscribers during the fourth quarter, highlighting its ability to attract and retain a growing customer base. With a track record of strong growth and an eye toward cross-selling opportunities, the company has the potential to further enhance its revenue per subscriber.

From a valuation perspective, Hims & Hers remains reasonably priced, especially in comparison to other technology companies. Despite its rapid growth rate, the company's price-to-sales ratio (P/S) is only 4, suggesting room for potential upside as the market recognizes its long-term potential.

In summary, Hims & Hers Health is well-positioned to capitalize on the expanding telehealth market. With a growing subscriber base, untapped market opportunities, and a reasonable valuation, the company offers an attractive investment prospect for those seeking exposure to the evolving landscape of telemedicine.

GOODRX HOLDINGS INC. (NASDAQ: GDRX)

GDRX is a leading digital healthcare platform that empowers consumers to compare drug prices and access cost savings. By partnering with pharmaceutical and health insurance providers, GoodRx offers discounted rates on prescription medications. While not a telemedicine company, GoodRx's platform complements telemedicine services by providing consumers with affordable healthcare options.

In the first quarter of 2023, GoodRx achieved impressive financial results, including total revenue of $184.0 million, surpassing previously announced guidance. The company reported a net loss of $3.3 million, with a net loss margin of 1.8%. Adjusted net income reached $29.5 million, and adjusted EBITDA amounted to $53.2 million, both exceeding earlier projections.

Key highlights from the quarter include over 450,000 engaged prescribers and a consumer base of over 7 million individuals utilizing prescription-related offerings. GoodRx remains committed to its mission of delivering affordable healthcare, with Chairman Trevor Bezdek expressing enthusiasm for the company's growth trajectory and the appointment of Scott Wagner as Interim CEO, expecting accelerated performance and expansion.

Despite challenges faced over the past year, GoodRx continues to innovate and add value to consumers and the broader healthcare ecosystem. Notably, the company's financial overview demonstrates a resilient business model. While prescription transactions revenue decreased due to shifts in volume and pricing, subscription revenue increased by 26%. GoodRx maintains a disciplined approach to capital allocation, prioritizing profitable growth, debt reduction, share repurchases, and strategic M&A.

In summary, GoodRx's strong financial performance, growing prescriber network, and expanding consumer base position the company for continued success in providing accessible and affordable healthcare solutions.

TELADOC HEALTH INC. (OTC: TDOC)

While TDOC is one of the more established companies in the telemedicine and telehealth fields, TDOC has experienced some turmoil in their stock since the covid boom. Teladoc Health is a leading provider of virtual healthcare services worldwide. The company operates through two segments: Integrated Care and BetterHelp. It offers virtual medical services, including general and specialized care, chronic condition management, and mental health support. Teladoc serves employers, health plans, hospitals, insurance companies, and individuals.

Teladoc's stock has experienced significant volatility over the last two years or so, reaching a high of $308 in February 2021 and a low of $21.60 in the same year. The company capitalized on the increased demand for virtual care during the COVID-19 pandemic, and while visit numbers have slowed since then, virtual care remains cost-effective and customer-friendly.

Despite its market presence, Teladoc has not yet achieved profitability since going public in 2015. It has pursued an aggressive growth strategy through acquisitions, R&D, and marketing. While revenue has grown by 1,199% in the past decade, the company has not reported a profitable quarter.

In the first quarter, Teladoc reported $629.2 million in revenue, up 11% year over year. However, it also recorded a loss of $69.2 million, or $0.42 in EPS. Teladoc does not anticipate turning a profit in 2023, with projected EPS losses between $1.70 and $1.25.

Teladoc's revenue growth has been fueled by strategic acquisitions, including Livongo Health for $18.5 billion in 2020, which focuses on chronic-care management. Teladoc also acquired Advance Medical for $352 million in 2018, expanding its presence in home healthcare, and Best Doctors for $440 million in 2017, a medical consultation company.

Teladoc Health presents opportunities as a major player in the telehealth industry, though it faces financial challenges and has yet to achieve profitability. The company continues to pursue growth through acquisitions and expansion into new markets.

Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) has been retained by Bullzeye Media to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR is not a fiduciary by virtue of any person's use of or access to this content.

Media Contact
Company Name: RazorPitch
Contact Person: Mark McKelvie
Email: Send Email
City: NAPLES
State: Florida
Country: United States
Website: https://razorpitch.com/

Featured

Must View

DTECH Data Centers & AI 2025

May 27-29, 2025 | San Jose, CA

Renewables

Hydropower

Power Grid

Webinars

Mar 27

Mar 26

Mar 26

Emerging Stocks in Telehealth: (MGRX, HIMS, GDRX, TDOC)